ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma

BACKGROUND: Integrin α5 (ITGA5) was involved in a variety of cancers. However, the role of ITGA5 in laryngeal squamous cell carcinoma (LSCC) remains unknown. METHODS: The expression of ITGA5 and the corresponding clinicopathological parameters of LSCC patients the TCGA database. Five datasets (GSE51...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chongchang, Shen, Yiming, Wei, Zhengyu, Shen, Zhisen, Tang, Ming, Shen, Yi, Deng, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841133/
https://www.ncbi.nlm.nih.gov/pubmed/34994984
http://dx.doi.org/10.1002/jcla.24228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841133/
https://www.ncbi.nlm.nih.gov/pubmed/34994984
http://dx.doi.org/10.1002/jcla.24228

Ejemplares similares